Alivira Animal Health Limited
Alan Kelly currently serves as the Vice President of Business at Alivira Animal Health Limited, a position held since September 2019. Prior to this role, Alan Kelly had a lengthy tenure at Bimeda Inc, where from January 1988 to August 2019, responsibilities included serving as Director of Commercial Development and dbod. Alan Kelly's extensive experience in the animal health sector underscores a robust professional background in business development and commercial strategy.
This person is not in any offices
Alivira Animal Health Limited
Alivira Animal Health Limited has emerged as India's largest and 1st Global integrated animal health company specialising in manufacturing of Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF) with presence in 100+ countries. Our eight manufacturing facilities based in India, Spain, Germany, Brazil and Turkey have approvals from top global regulatory bodies, including USFDA, EUGMP, WHO, TGA, among others. We offer a comprehensive portfolio across formulations, animal health Active Pharmaceutical Ingredients (API), and provide analytical services to the pharmaceutical and life sciences industry. Alivira Animal Health Limited is a 100% subsidiary of Sequent Scientific Limited, a company listed in India on the Bombay Stock Exchange (BSE) and National Stock exchange (NSE).